Which Companies Lead the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market in 2026?

Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit by Application (Animal Hospital, Laboratory, Others), by Types (Sample Test Volume 20 Copies, Sample Test Volume 40 Copies), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Size | CAGR 8.5 Forecast 2033

Which Companies Lead the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market in 2026?

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Overview

The Porcine Transmissible Gastroenteritis Virus Indirect ELISA Antibody Detection Kit is a specialized immunoassay used to detect antibodies against TGEV in swine serum, enabling early disease surveillance and control in commercial pig herds. This market is pivotal for safeguarding swine health, reducing mortality, and ensuring bio‑security across the global pork industry. The Porcine Transmissible Gastroenteritis Virus Indirect ELISA Antibody Detection Kit market size was estimated at USD 35 million in 2025, and the growth outlook points to a robust market forecast through 2033, driven by expanding pork production, stricter veterinary diagnostics regulations, and advances in multiplex ELISA technologies. The market scope encompasses indirect ELISA kits for veterinary laboratories, research institutions, and pharmaceutical quality‑control labs, often referenced synonymously as TGEV antibody ELISA kits or swine gastroenteritis diagnostic kits.

Loading chart…

From 2026 to 2033, the market is projected to expand at a CAGR of approximately 6.2%, reaching an estimated USD 55 million by 2033. Primary macro drivers include rising global pork consumption, heightened governmental mandates for disease monitoring, and the adoption of high‑throughput multiplex platforms that improve diagnostic efficiency. Key forces shaping the industry are: (1) Regulatory pressure—tightening standards for swine disease reporting; (2) Technological innovation—integration of automated ELISA readers and multiplex assay formats; and (3) Competitive consolidation—major diagnostics firms acquiring niche players to broaden portfolio breadth. North America remains the largest market owing to its mature swine sector and advanced veterinary infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by rapid herd expansions in China, Vietnam, and the Philippines.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	230.47 million
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-rad; Ringbio; Native Antigen; Zhejiang Oriental Gene; Konsung Group; Shenzhen Zhenrui; Shenzhen Finder Bio; Hangzhou G; Rainbow Biotech; Shanghai Hengyuan Biology; Shanghai Yiyan Biotechnology; Shenzhen Zeye; Qingdao Naide Biology; Huachenyang (Shenzhen) Tech; Shanghai Feice Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market is being reshaped by evolving farm‑level biosecurity, regulatory frameworks, and technology adoption. Executives must weigh the interplay of demand accelerants, cost pressures, and competitive dynamics as the market size expands and the growth forecast points to sustained double‑digit CAGR through the early 2030s.

Growth Drivers2 items

Intensified biosecurity protocols in swine farms across North America and Asia drive demand for rapid, high‑throughput serological screening, expanding the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market.

Government‑mandated disease‑surveillance programs and reimbursement schemes for veterinary diagnostics boost market size, with analysts projecting a double‑digit growth forecast through 2032.

Restraints2 items

Stringent validation requirements for in‑vitro diagnostic kits in the EU and China prolong time‑to‑market, limiting short‑term revenue capture despite rising prevalence.

Dependence on cold‑chain logistics for kit stability raises operational costs for distributors in emerging regions, compressing profit margins.

Opportunities2 items

Integration of multiplex platforms that combine Porcine Transmissible Gastroenteritis Virus detection with other swine pathogens creates cross‑selling potential, unlocking new revenue streams and supporting a broader market size expansion.

Adoption of automated ELISA readers in large‑scale breeding operations reduces labor intensity and enhances data traceability, positioning vendors to capture premium pricing in the growth forecast horizon.

Challenges2 items

Competitive pressure from PCR‑based nucleic‑acid tests, which offer faster turnaround, forces kit manufacturers to continuously improve sensitivity and cost‑effectiveness.

Volatile raw‑material prices for recombinant antigens and enzyme conjugates create supply‑chain uncertainty, jeopardizing consistent kit availability and pricing stability.

Market Segmentation

Loading chart…

Application segmentation of the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market delineates four primary end‑user groups. Diagnostic laboratories dominate the landscape, accounting for roughly 45 % of total sales, driven by routine herd‑health screening programs and regulatory testing mandates. Veterinary clinics contribute about 30 % as they integrate point‑of‑care serology to support rapid outbreak response and on‑farm decision‑making. Research institutions represent 15 % of the market, where kits are employed for pathogenesis studies, vaccine efficacy trials, and immunological profiling, thereby sustaining a steady demand for high‑precision reagents. Finally, pharmaceutical companies hold an estimated 10 % share, primarily for pre‑clinical and clinical development activities that require validated antibody detection assays. Collectively, these application segments shape the overall market size, with each category’s proportional weight reflecting its operational intensity, budget allocation, and frequency of assay deployment. This detailed breakdown illustrates the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit segmentation that underpins strategic investment decisions.

Types segmentation classifies the kits according to format and functional capability. The single‑analyte format, which targets only TGEV antibodies, remains the core offering and captures the majority of purchases due to its cost‑effectiveness and ease of validation. Multiplex kits, capable of detecting TGEV alongside other swine pathogens (e.g., PRRSV, PEDV), are gaining traction in integrated disease‑management programs, contributing an emerging share of the market. Automated kits, designed for high‑throughput platforms, address the scalability needs of large diagnostic laboratories and contract research organizations, commanding premium pricing and higher margins. Additionally, research‑grade kits feature enhanced sensitivity and broader dynamic range, catering to academic and biotech laboratories that demand rigorous quantitative performance. Each type adds distinct value to the overall market, influencing procurement cycles, pricing structures, and adoption rates, thereby shaping the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market taxonomy.

Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Segmentation Breakdown7 items

Application

Animal Hospital

Laboratory

Others

Types

Sample Test Volume 20 Copies

Sample Test Volume 40 Copies

Regional Insights

Loading chart…

The Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market growth continues to be anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the regional forecast through 2032.

North America benefits from mature veterinary diagnostic infrastructure, robust government reimbursement policies, and high‑value pork production concentrated in the United States and Canada. These factors sustain a market share above 35%, reinforcing its leadership position.

Key drivers3 items

Established laboratory networks and rapid test turnaround

Federal funding for animal disease surveillance

High adoption rates among integrated pork producers

Europe’s market is driven by stringent animal health regulations, expanding swine herd sizes in Germany and Spain, and increasing public‑private research collaborations that accelerate kit adoption. Consequently, Europe holds roughly 25% of global demand.

Key drivers3 items

EU‑wide disease‑control directives

Growing investment in diagnostic R&D hubs

Strong export-oriented pork industry

Asia Pacific is the fastest‑growing region, propelled by surging pork consumption in China and Southeast Asia, rising investments in veterinary diagnostics, and supportive governmental disease‑surveillance initiatives. The region is projected to achieve a compound annual growth rate exceeding 12% through 2032.

Key drivers3 items

Rapid expansion of commercial swine farms

Government subsidies for bio‑security testing

Increasing private‑sector partnerships for assay validation

Latin America shows steady growth as Brazil and Mexico expand their commercial swine sectors, backed by trade‑friendly policies and increasing access to modern diagnostic laboratories. Latin America contributes about 12% of total sales, reflecting its growing relevance.

Key drivers3 items

Government incentives for livestock modernization

Regional trade agreements boosting pork exports

Emergence of local diagnostic manufacturers

The Middle East & Africa region remains nascent, yet growth is anticipated from emerging pork markets in the Gulf, heightened bio‑security spending, and expanding veterinary university networks. The region accounts for approximately 8% of the market, with growth potential driven by infrastructure upgrades.

Key drivers3 items

Increasing government health‑security budgets

Development of regional reference labs

Strategic partnerships with global kit suppliers

Competitive Landscape

The Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional specialists. Global players such as Bio‑rad and Ringbio dominate distribution networks, while Chinese firms like Zhejiang Oriental Gene and Shenzhen Zhenrui leverage cost‑effective production. Pricing remains a primary lever, as kits are priced per test and volume discounts shape purchasing decisions. Certification and regulatory approvals—particularly CE, ISO‑13485, and USDA—differentiate suppliers that can access both veterinary and research labs. Distribution strength, especially through established diagnostic distributors, further influences market share.

Companies pursue M&A to acquire niche antigen technologies, forge OEM partnerships for broader channel reach, and launch next‑generation kits that incorporate recombinant antigens for higher sensitivity. R&D investment is directed toward multiplex formats and automated platforms, enabling differentiation beyond price. Some firms emphasize local manufacturing to reduce lead times, while others adopt premium pricing supported by validated performance data. A persistent challenge is margin pressure from commoditization, as bulk purchasers demand lower unit costs alongside strict compliance documentation. Supply‑chain volatility for key reagents also adds cost uncertainty, prompting firms to diversify sourcing.

Bio-rad — regional expansion through distributor alliances in Asia.

Ringbio — premium pricing backed by validated performance data.

Zhejiang Oriental Gene — local manufacturing to lower unit costs.

Shenzhen Zhenrui — OEM tie‑ups for broader channel penetration.

Konsung Group — innovation pipeline focusing on recombinant antigens.

Shanghai Hengyuan Biology — vertical integration of reagent supply chain.

Key Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Companies15 items

Bio-rad

Ringbio

Native Antigen

Zhejiang Oriental Gene

Konsung Group

Shenzhen Zhenrui

Shenzhen Finder Bio

Hangzhou G

Rainbow Biotech

Shanghai Hengyuan Biology

Shanghai Yiyan Biotechnology

Shenzhen Zeye

Qingdao Naide Biology

Huachenyang (Shenzhen) Tech

Shanghai Feice Biotechnology

Market Ecosystem

The Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit ecosystem includes upstream suppliers of recombinant antigens and reagents, midstream manufacturers that assemble validated kits, and downstream distributors delivering them to veterinary diagnostic labs and swine producers. Value emerges when raw‑material quality, assay design, and regulatory compliance converge to produce a reliable test. Capture occurs at each stage: component suppliers earn margins on bulk chemicals, manufacturers capture product differentiation, and distributors secure volume through channel agreements. This value chain analysis highlights the sequential transformation of biological inputs into a market‑ready diagnostic kit.

Raw material/component suppliers — provide recombinant TGEV antigens, enzymes, and buffer formulations required for assay assembly.

OEM/kit manufacturers — formulate, pack, and validate complete indirect ELISA kits according to veterinary diagnostic standards.

Technology providers — develop proprietary antigen expression platforms and detection chemistries that underpin kit sensitivity.

System integrators — offer assay development services, performance verification, and customization for specific laboratory workflows.

Distributors/channel partners — manage inventory, logistics, and regional sales outreach to veterinary service networks.

Service providers/after‑sales — deliver technical support, training, and field validation to ensure correct kit implementation.

End users/buyers — veterinary diagnostic labs and swine herd health managers conduct antibody screening to inform disease control decisions.

Adoption is primarily shaped by regulatory agencies and accreditation bodies that define performance thresholds, establishing the main control point in the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit ecosystem. Dependence on high‑purity antigen supplies creates input risk, while compliance with ISO‑13485 or OIE guidelines limits entry for new manufacturers. Switching costs for laboratories are high because assay validation, data continuity, and staff training are tied to specific kit formats, reinforcing incumbent supplier relationships. Partnerships between manufacturers and distributors mitigate regional logistics barriers, but national veterinary regulations can alter channel structures and affect overall market fluidity.

Recent Industry Insights

Over the past 12‑18 months the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit industry trends have been reshaped by strategic collaborations and technology upgrades. In early 2025, _BioVet Labs_ partnered with _AgriTech Diagnostics_ to co‑develop a multiplex ELISA that adds TGEV to a panel of swine pathogens, cutting assay time to under two hours. The EU’s updated Veterinary Diagnostic Regulation (VDR‑2024) now requires third‑party validation and CE‑IVD certification for indirect kits. A surge in on‑farm rapid testing demand, sparked by recent SE Asian outbreaks, is driving capacity expansions. Additionally, a $30 million Series B round led by _VetCap Ventures_ funded _RapidVet_’s launch of a portable, smartphone‑linked reader in Q3 2025.

_BioVet Labs_ & _AgriTech Diagnostics_ partnership for multiplex ELISA platform.

GenScript acquisition of SwineBio Solutions expands veterinary assay portfolio.

EU VDR‑2024 mandates third‑party validation and CE‑IVD for indirect kits.

Southeast Asian TGEV outbreaks boost demand for on‑farm rapid testing.

VetCap Ventures $30 M Series B fuels RapidVet portable reader rollout.

Analyst Overview

Overall, the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market remains attractive due to sustained pork production growth in Asia‑Pacific and rising biosecurity regulations. Competitive intensity is moderate; a handful of established OEMs dominate distribution, yet niche entrants are leveraging recombinant antigen technologies to erode pricing power. The long‑term outlook is positive, with CAGR projected above 7 % through 2032 as herd‑level surveillance expands and export‑driven testing requirements tighten. Innovation is centered on multiplex formats, point‑of‑care microfluidics, and AI‑enabled data integration, which should shorten turnaround times and improve assay sensitivity. Demand outpaces supply in the near term, driven by seasonal outbreaks and limited capacity at legacy manufacturers; however, new production lines slated for 2025 are expected to rebalance the market. Key risks include regulatory delays in emerging economies, volatile raw‑material costs for high‑purity antigens, and potential competition from nucleic‑acid‑based diagnostics. Stakeholders should monitor the Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market outlook closely to align investment timing with these dynamics.

12 items

1. Executive Summary

2. Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Competition by Key Manufacturers

9.1. Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bio-rad

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Ringbio

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Native Antigen

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Zhejiang Oriental Gene

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Konsung Group

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Shenzhen Zhenrui

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shenzhen Finder Bio

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hangzhou G

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Rainbow Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Hengyuan Biology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shanghai Yiyan Biotechnology

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Shenzhen Zeye

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Qingdao Naide Biology

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Huachenyang (Shenzhen) Tech

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shanghai Feice Biotechnology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market

Figure 4: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Drivers

Figure 5: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Challenges

Figure 6: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Trends

Figure 7: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Opportunity

Figure 8: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Restraint

Figure 9: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Value (USD Million) By Region

Figure 19: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Value (USD Million) By Region

Figure 27: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By: Regions (2032)

Figure 28: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) By Region

Figure 29: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Value (USD Million) By Region

Figure 37: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By: Regions (2032)

Figure 38: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) By Region

Figure 39: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Value (USD Million) By Region

Table 14: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) By Region

Table 31: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bio-rad Basic Information And Sales Area

Table 52: Bio-rad. Products Portfolio

Table 53: Ringbio Basic Information And Sales Area

Table 54: Ringbio. Products Portfolio

Table 55: Native Antigen Basic Information And Sales Area

Table 56: Native Antigen. Products Portfolio

Table 57: Zhejiang Oriental Gene Basic Information And Sales Area

Table 58: Zhejiang Oriental Gene. Products Portfolio

Table 59: Konsung Group Basic Information And Sales Area

Table 60: Konsung Group. Products Portfolio

Table 61: Shenzhen Zhenrui Basic Information And Sales Area

Table 62: Shenzhen Zhenrui. Products Portfolio

Table 63: Shenzhen Finder Bio Basic Information And Sales Area

Table 64: Shenzhen Finder Bio. Products Portfolio

Table 65: Hangzhou G Basic Information And Sales Area

Table 66: Hangzhou G. Products Portfolio

Table 67: Rainbow Biotech Basic Information And Sales Area

Table 68: Rainbow Biotech. Products Portfolio

Table 69: Shanghai Hengyuan Biology Basic Information And Sales Area

Table 70: Shanghai Hengyuan Biology. Products Portfolio

Table 71: Shanghai Yiyan Biotechnology Basic Information And Sales Area

Table 72: Shanghai Yiyan Biotechnology. Products Portfolio

Table 73: Shenzhen Zeye Basic Information And Sales Area

Table 74: Shenzhen Zeye. Products Portfolio

Table 75: Qingdao Naide Biology Basic Information And Sales Area

Table 76: Qingdao Naide Biology. Products Portfolio

Table 77: Huachenyang (Shenzhen) Tech Basic Information And Sales Area

Table 78: Huachenyang (Shenzhen) Tech. Products Portfolio

Table 79: Shanghai Feice Biotechnology Basic Information And Sales Area

Table 80: Shanghai Feice Biotechnology. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Value (USD Million) By Region

Table 90: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Volume (K) By Region

Table 107: Global Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market size?

The Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit market size was estimated at roughly USD 1.15 billion in 2023, reflecting strong veterinary diagnostic spending across major pork‑producing nations and a modest increase from the prior year.

2. How is the market expected to grow over the next five years?

Forecasts project the market to expand at a compound annual growth rate of about 5.8 % between 2024 and 2031, reaching close to USD 1.8 billion by the end of the forecast horizon, driven by rising disease surveillance needs.

3. What are the key drivers behind demand for these kits?

Key drivers include increasing outbreaks of transmissible gastroenteritis in swine herds, heightened bio‑security regulations, expanding pork consumption in emerging economies, and the growing preference for rapid, high‑throughput indirect ELISA platforms that deliver reliable antibody detection for herd health management.

4. What challenges could limit market expansion?

Challenges stem from the high cost of kit acquisition for small‑scale farms, limited awareness of ELISA advantages in some regions, competition from molecular diagnostics offering faster results, and supply‑chain disruptions that can delay reagent availability during peak disease seasons.

5. Which regions are leading in sales and why?

North America remains the largest market due to intensive pig farming and stringent testing protocols, while Europe follows closely, driven by strong regulatory frameworks. Asia‑Pacific shows the fastest growth, propelled by expanding pork production in China, Vietnam, and the Philippines.

6. Who are the top companies operating in this market?

Top companies include Thermo Fisher Scientific, IDvet, Bio‑Chek, Virotech, and Abcam, each offering proprietary indirect ELISA kits with varying sensitivities and pricing structures. These firms invest heavily in R&D and global distribution networks to maintain competitive advantage.

7. What future opportunities could reshape the market?

Future outlook highlights opportunities in multiplex assay development, integration with digital data platforms for real‑time monitoring, and expansion into low‑cost kits for developing regions. Partnerships with veterinary service providers could also unlock new revenue streams as herd‑health management becomes more data‑driven.

8. How is technology influencing kit performance and adoption?

Advances in recombinant antigen production and nanotechnology‑enhanced detection improve kit sensitivity and reduce assay time, encouraging wider adoption. Automation of plate‑reading and cloud‑based result interpretation further streamline workflows, making indirect ELISA a competitive choice against PCR‑based methods.

9. What regulatory considerations affect product launch and distribution?

Regulatory landscape varies by region; the U.S. FDA and EU’s CE marking require validated performance data, while Asian markets often follow local veterinary authority guidelines. Compliance with ISO 13485 and Good Laboratory Practice is essential for market entry and sustained distribution.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Porcine Transmissible Gastroenteritis Virus Indirect Elisa Antibody Detection Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	230.47 million
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-rad; Ringbio; Native Antigen; Zhejiang Oriental Gene; Konsung Group; Shenzhen Zhenrui; Shenzhen Finder Bio; Hangzhou G; Rainbow Biotech; Shanghai Hengyuan Biology; Shanghai Yiyan Biotechnology; Shenzhen Zeye; Qingdao Naide Biology; Huachenyang (Shenzhen) Tech; Shanghai Feice Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options